Logo Teleflex

Teleflex (TFX) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
Teleflex · Health Care · ref. ETF XLV · 92 calls · price $137.71
🏆JPI 2026 portfoliosSee tracking →
What the company does: Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally.

📈 Teleflex (TFX) stock price

$137.71+9.1% over range
Aug 28, 25low $100.34 · high $140.18Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
56% recommend buying · 9 analysts
📊 JPI status : Teleflex has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 TFX price target & analyst consensusprice $138

The price target · all analysts combined (9 targets)
Highest target · 1 firm of 9$170+23.4%
Median target · of 9 targets$155+12.6%
Lowest target · 1 firm of 9$128-7.1%
Current price$137.71
Where these 9 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 889% $138 ↔ $170
Below 111% $128
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS58% of its targets hit on this sector (74 calls tested). It aims for $158 (+15 %), call made on August 12, 2026, maturing on August 12, 2027 (16 d ago).

The 1 reliable analyst $158+15 %
The 8 other firms $153+11 %
How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $158 median. “The 8 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 9 ratings (last 6 months)
Strong Buy00%
Buy556%
Hold444%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Teleflex? The JPI assistant answers using our backtest data.

🔎 Detailed analyses

🏛️ Which US Congress members hold Teleflex (TFX)?

2 Congress members have disclosed TFX buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Susie Lee · 43%Daniel Goldman · 25%
→ Full members ranking (who beats the market)

✅ Historical analyst reliability on TFX

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
Brean Capital 100% +30.3% 4
Jefferies  100% +28.5% 2
UBS  100% +18.3% 4
Barclays  100% +13.4% 3
Leerink Swann 100% +10.9% 2
Wells Fargo  75% +6.5% 4
Morgan Stanley  74% +8.7% 19
Needham  50% +5.6% 8
SVB Leerink 50% -6.3% 6
Keybanc  50% -8.2% 4
See the other 6 firms
Wolfe Research  0% -6.1% 2
RBC Capital  11% -18.4% 19
JMP Securities 36% -5.2% 14
Raymond James  44% -2.5% 25
Stephens & Co.  45% -0.1% 11
Piper Sandler  50% -14.4% 2

📊 What $1,000 invested in Teleflex would be worth › open the full page

In short — $1,000 invested in Teleflex 10 years ago would be worth $911 today, i.e. -1%/yr on average. Best year: 2016 (+34%), worst: 2024 (-40%). Price performance, excluding dividends.

If I'd invested $1,000 in Teleflex

InvestmentWorth todayGain
1 years ago$980-2%
3 years ago$546-45%
5 years ago$327-67%
→ See Teleflex's full return history + gain calculator

Return by year (Teleflex)

YearReturn$1,000 invested at year start
2026 (YTD)+7%$1,066 (+7%)
2025-8%$980 (-2%)
2024-40%$584 (-42%)
→ See Teleflex's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Teleflex

Loading news…

📋 All analyst calls on TFX

Needham 
Aug 25, 26
▲ Buy · 🎯$170
Price at call : $140.18 — upside +21%
Today : $137.71 — upside +23%
🎯 on TFX : no call matured yet · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Aug 25, 27
UBS 
Aug 11, 26
■ Neutral neutral · not a buy · 🎯$158
Price at call : $136.32 — gap to target +16%
Today : $137.71 — gap to target +15%
🎯 on TFX : no call matured yet · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Aug 11, 27
■ Hold neutral · not a buy · 🎯$150
Price at call : $133.54 — gap to target +12%
Today : $137.71 — gap to target +9%
🎯 on TFX : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Aug 10, 27
Piper Sandler 
Aug 7, 26
▲ Overweight · 🎯$169
Price at call : $133 — upside +27%
Today : $137.71 — upside +23%
🎯 on TFX : no call matured yet · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Aug 7, 27
Needham 
Jul 31, 26
▲ Buy · 🎯$159
Price at call : $136.71 — upside +16%
Today : $137.71 — upside +15%
🎯 on TFX : no call matured yet · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Jul 31, 27
UBS 
Jul 28, 26
■ Neutral neutral · not a buy · 🎯$145
Price at call : $134.65 — gap to target +8%
Today : $137.71 — gap to target +5%
🎯 on TFX : no call matured yet · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Jul 28, 27
Mizuho 
Jul 15, 26
■ Neutral neutral · not a buy · 🎯$145
Price at call : $135.22 — gap to target +7%
Today : $137.71 — gap to target +5%
🎯 on TFX : no call matured yet · 📊 on Health : 26.4% · -9.4% (87 calls)
in progress (365j)
matures : Jul 15, 27
BMO Capital 
Jul 9, 26
▲ Outperform · 🎯$159
Price at call : $135.73 — upside +17%
Today : $137.71 — upside +15%
🎯 on TFX : no call matured yet · 📊 on Health : 43.9% · -2.1% (66 calls)
in progress (365j)
matures : Jul 9, 27
See the other 84 calls, newest to oldest
Piper Sandler 
Jun 8, 26
▲ Overweight · 🎯$160
Price at call : $135.75 — upside +18%
Today : $137.71 — upside +16%
🎯 on TFX : no call matured yet · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Jun 8, 27
■ Hold neutral · not a buy · 🎯$143
Price at call : $129.03 — gap to target +11%
Today : $137.71 — gap to target +4%
🎯 on TFX : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : May 11, 27
RBC Capital 
May 8, 26
▲ Outperform · 🎯$155
Price at call : $129.72 — upside +19%
Today : $137.71 — upside +13%
🎯 on TFX : 0% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : May 8, 27
Wells Fargo 
May 8, 26
■ Equal-Weight neutral · not a buy · 🎯$138
Price at call : $133.06 — gap to target +4%
Today : $137.71 — gap to target +0%
🎯 on TFX : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : May 8, 27
Raymond James 
Mar 27, 26
▲ Outperform · 🎯$128
Price at call : $114.93 — upside +11%
Today : $137.71 — upside -7%
🎯 on TFX : 8% (12 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
in progress (365j)
matures : Mar 27, 27
RBC Capital 
Feb 27, 26
■ Sector Perform neutral · not a buy · 🎯$125
Price at call : $122.93 — gap to target +2%
Today : $137.71 — gap to target -9%
🎯 on TFX : 0% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Feb 27, 27
Wells Fargo 
Feb 27, 26
■ Equal-Weight neutral · not a buy · 🎯$130
Price at call : $122.93 — gap to target +6%
Today : $137.71 — gap to target -6%
🎯 on TFX : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Feb 27, 27
Needham 
Feb 26, 26
▲ Buy · 🎯$147
Price at call : $119.02 — upside +24%
Today : $137.71 — upside +7%
🎯 on TFX : no call matured yet · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Feb 26, 27
Wells Fargo 
Jan 29, 26
■ Equal-Weight neutral · not a buy · 🎯$116
Price at call : $105.48 — gap to target +10%
Today : $137.71 — gap to target -16%
🎯 on TFX : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Jan 29, 27
Needham 
Jan 27, 26
▲ Buy · 🎯$138
Price at call : $104.52 — upside +32%
Today : $137.71 — upside +0%
🎯 on TFX : no call matured yet · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Jan 27, 27
■ Hold neutral · not a buy · 🎯$135
Price at call : $121.89 — gap to target +11%
Today : $137.71 — gap to target -2%
🎯 on TFX : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Dec 18, 26
Wells Fargo 
Dec 10, 25
■ Equal-Weight neutral · not a buy · 🎯$139
Price at call : $127.25 — gap to target +9%
Today : $137.71 — gap to target +1%
🎯 on TFX : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Dec 10, 26
■ Hold neutral · not a buy · 🎯$120
Price at call : $112.26 — gap to target +7%
Today : $137.71 — gap to target -13%
🎯 on TFX : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Nov 10, 26
RBC Capital 
Nov 7, 25
■ Sector Perform neutral · not a buy · 🎯$120
Price at call : $107.97 — gap to target +11%
Today : $137.71 — gap to target -13%
🎯 on TFX : 0% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Nov 7, 26
Wells Fargo 
Nov 7, 25
■ Equal-Weight neutral · not a buy · 🎯$114
Price at call : $107.97 — gap to target +6%
Today : $137.71 — gap to target -17%
🎯 on TFX : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Nov 7, 26
Mizuho 
Aug 1, 25
■ Neutral neutral · not a buy · 🎯$135
Price at call : $116.06 — gap to target +16%
Today : $137.71 — gap to target -2%
🎯 on TFX : no call matured yet · 📊 on Health : 26.4% · -9.4% (87 calls)
in progress (365j)
matures : Aug 1, 26
RBC Capital 
Aug 1, 25
■ Sector Perform neutral · not a buy · 🎯$135
Price at call : $116.06 — gap to target +16%
Today : $137.71 — gap to target -2%
🎯 on TFX : 0% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Aug 1, 26
Wells Fargo 
Aug 1, 25
■ Equal-Weight neutral · not a buy · 🎯$131
Price at call : $116.06 — gap to target +13%
Today : $137.71 — gap to target -5%
🎯 on TFX : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Aug 1, 26
Mizuho 
Jul 16, 25
■ Neutral neutral · not a buy · 🎯$130
Price at call : $113.32 — gap to target +15%
Today : $137.71 — gap to target -6%
🎯 on TFX : no call matured yet · 📊 on Health : 26.4% · -9.4% (87 calls)
in progress (365j)
matures : Jul 16, 26
RBC Capital 
Jul 15, 25
■ Sector Perform neutral · not a buy · 🎯$130
Price at call : $113.32 — gap to target +15%
Today : $137.71 — gap to target -6%
🎯 on TFX : 0% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Jul 15, 26
■ Hold neutral · not a buy · 🎯$137
Price at call : $120.57 — gap to target +14%
Today : $137.71 — gap to target -1%
🎯 on TFX : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : May 5, 26
▲ Overweight · 🎯$173
Price at call : $120.57 — upside +43%
Today : $137.71 — upside +26%
Expected +43% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 58% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+2.2%
stock +2% · XLV +8%
matured May 5, 26
RBC Capital 
May 2, 25
■ Sector Perform neutral · not a buy · 🎯$145
Price at call : $122.9 — gap to target +18%
Today : $137.71 — gap to target +5%
🎯 on TFX : 0% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : May 2, 26
Wells Fargo 
May 2, 25
■ Equal-Weight neutral · not a buy · 🎯$137
Price at call : $122.9 — gap to target +11%
Today : $137.71 — gap to target -1%
🎯 on TFX : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : May 2, 26
■ Hold neutral · not a buy · 🎯$140
Price at call : $132.09 — gap to target +6%
Today : $137.71 — gap to target +2%
🎯 on TFX : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Apr 11, 26
■ Market Perform neutral · not a buy
🎯 on TFX : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Apr 2, 26
Needham 
Mar 12, 25
■ Hold neutral · not a buy
🎯 on TFX : no call matured yet · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Mar 12, 26
▲ Overweight · 🎯$191
Price at call : $134.17 — upside +42%
Today : $137.71 — upside +39%
Expected +42% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 58% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
-12.4%
stock -12% · XLV +3%
matured Mar 5, 26
▼ Underperform · 🎯$140
Price at call : $130.79 — upside +7%
Today : $137.71 — upside +2%
Expected +7% · Actual -9% · Reason (≤ −15%) : ✗ No
🎯 on TFX : 100% (1 call matured) · 📊 on Health : 51.3% · +3.0% (152 calls)
+8.9%
stock -9% · XLV +6%
matured Mar 4, 26
■ Hold neutral · not a buy · 🎯$149
Price at call : $130.79 — gap to target +14%
Today : $137.71 — gap to target +8%
🎯 on TFX : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Mar 3, 26
Wells Fargo 
Feb 28, 25
■ Equal-Weight neutral · not a buy · 🎯$146
Price at call : $135.13 — gap to target +8%
Today : $137.71 — gap to target +6%
🎯 on TFX : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Feb 28, 26
Piper Sandler 
Feb 28, 25
■ Neutral neutral · not a buy · 🎯$140
Price at call : $132.75 — gap to target +5%
Today : $137.71 — gap to target +2%
🎯 on TFX : no call matured yet · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Feb 28, 26
■ Hold neutral · not a buy · 🎯$200
Price at call : $174.79 — gap to target +14%
Today : $137.71 — gap to target +45%
🎯 on TFX : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Dec 18, 25
Needham 
Dec 16, 24
■ Hold neutral · not a buy
🎯 on TFX : no call matured yet · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Dec 16, 25
■ Hold neutral · not a buy · 🎯$227
Price at call : $203.5 — gap to target +12%
Today : $137.71 — gap to target +65%
🎯 on TFX : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Nov 4, 25
Mizuho 
Nov 1, 24
■ Neutral neutral · not a buy · 🎯$250
Price at call : $207.33 — gap to target +21%
Today : $137.71 — gap to target +82%
🎯 on TFX : no call matured yet · 📊 on Health : 26.4% · -9.4% (87 calls)
in progress (365j)
matures : Nov 1, 25
RBC Capital 
Nov 1, 24
▲ Outperform · 🎯$245
Price at call : $207.33 — upside +18%
Today : $137.71 — upside +78%
Expected +18% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 0% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-40.8%
stock -41% · XLV -2%
matured Nov 1, 25
Needham 
Nov 1, 24
■ Hold neutral · not a buy
🎯 on TFX : no call matured yet · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Nov 1, 25
■ Hold neutral · not a buy · 🎯$255
Price at call : $235.38 — gap to target +8%
Today : $137.71 — gap to target +85%
🎯 on TFX : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Oct 14, 25
RBC Capital 
Oct 8, 24
▲ Outperform · 🎯$275
Price at call : $234.41 — upside +17%
Today : $137.71 — upside +100%
Expected +17% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 0% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-46.8%
stock -47% · XLV -6%
matured Oct 8, 25
RBC Capital 
Aug 6, 24
▲ Outperform · 🎯$260
Price at call : $230.83 — upside +13%
Today : $137.71 — upside +89%
Expected +13% · Actual -51% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 0% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-51.4%
stock -51% · XLV -12%
matured Aug 6, 25
■ Hold neutral · not a buy · 🎯$247
Price at call : $230.83 — gap to target +7%
Today : $137.71 — gap to target +79%
🎯 on TFX : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Aug 5, 25
RBC Capital 
Aug 2, 24
▲ Outperform · 🎯$260
Price at call : $233.33 — upside +11%
Today : $137.71 — upside +89%
Expected +11% · Actual -50% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 0% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-50.3%
stock -50% · XLV -9%
matured Aug 2, 25
▲ Overweight · 🎯$290
Price at call : $233.33 — upside +24%
Today : $137.71 — upside +111%
Expected +24% · Actual -50% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 45% (11 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
-50.3%
stock -50% · XLV -9%
matured Aug 2, 25
RBC Capital 
Feb 23, 24
▲ Outperform · 🎯$265
Price at call : $227.84 — upside +16%
Today : $137.71 — upside +92%
Expected +16% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 0% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-22.0%
stock -22% · XLV +0%
matured Feb 22, 25
RBC Capital 
Jan 12, 24
▲ Outperform · 🎯$272
Price at call : $245.91 — upside +11%
Today : $137.71 — upside +98%
Expected +11% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 0% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-27.4%
stock -27% · XLV +1%
matured Jan 11, 25
Raymond James 
Dec 20, 23
▲ Outperform · 🎯$271
Price at call : $247.61 — upside +9%
Today : $137.71 — upside +97%
Expected +9% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 8% (12 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
-29.4%
stock -29% · XLV +3%
matured Dec 19, 24
▲ Overweight
Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 58% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
-18.0%
stock -18% · XLV +11%
matured Dec 3, 24
RBC Capital 
Nov 3, 23
▲ Outperform · 🎯$228
Price at call : $213.03 — upside +7%
Today : $137.71 — upside +66%
Expected +7% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 0% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-2.7%
stock -3% · XLV +14%
matured Nov 2, 24
▲ Overweight · 🎯$275
Price at call : $213.03 — upside +29%
Today : $137.71 — upside +100%
Expected +29% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 45% (11 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
-2.7%
stock -3% · XLV +14%
matured Nov 2, 24
Stephens & Co. 
Oct 11, 23
▲ Overweight · 🎯$315
Price at call : $192.23 — upside +64%
Today : $137.71 — upside +129%
Expected +64% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on TFX : 45% (11 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
+22.1%
stock +22% · XLV +17%
matured Oct 10, 24
Raymond James 
Aug 7, 23
▲ Outperform · 🎯$255
Price at call : $240.17 — upside +6%
Today : $137.71 — upside +85%
Expected +6% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 8% (12 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
-3.9%
stock -4% · XLV +10%
matured Aug 6, 24
RBC Capital 
Aug 3, 23
▲ Outperform · 🎯$285
Price at call : $237.88 — upside +20%
Today : $137.71 — upside +107%
Expected +20% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 0% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-1.9%
stock -2% · XLV +11%
matured Aug 2, 24
Stephens & Co. 
Jul 27, 23
▲ Overweight · 🎯$315
Price at call : $252.32 — upside +25%
Today : $137.71 — upside +129%
Expected +25% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 45% (11 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
-11.8%
stock -12% · XLV +11%
matured Jul 26, 24
RBC Capital 
Jul 12, 23
▲ Outperform · 🎯$285
Price at call : $247.07 — upside +15%
Today : $137.71 — upside +107%
Expected +15% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 0% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-10.8%
stock -11% · XLV +14%
matured Jul 11, 24
RBC Capital 
Jun 12, 23
▲ Outperform · 🎯$285
Price at call : $239.06 — upside +19%
Today : $137.71 — upside +107%
Expected +19% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 0% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-11.7%
stock -12% · XLV +11%
matured Jun 11, 24
Raymond James 
May 8, 23
▲ Outperform · 🎯$272
Price at call : $259.18 — upside +5%
Today : $137.71 — upside +98%
Expected +5% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 8% (12 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
-22.3%
stock -22% · XLV +7%
matured May 7, 24
▲ Overweight · 🎯$305
Price at call : $259.18 — upside +18%
Today : $137.71 — upside +121%
Expected +18% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 45% (11 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
-22.5%
stock -22% · XLV +6%
matured May 4, 24
RBC Capital 
May 4, 23
▲ Outperform · 🎯$285
Price at call : $257.95 — upside +10%
Today : $137.71 — upside +107%
Expected +10% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 0% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-22.1%
stock -22% · XLV +6%
matured May 3, 24
Stephens & Co. 
Feb 24, 23
▲ Overweight · 🎯$290
Price at call : $238.93 — upside +21%
Today : $137.71 — upside +111%
Expected +21% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 45% (11 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
-4.6%
stock -5% · XLV +15%
matured Feb 24, 24
Raymond James 
Feb 24, 23
▲ Outperform · 🎯$259
Price at call : $235.18 — upside +10%
Today : $137.71 — upside +88%
Expected +10% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 8% (12 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
-3.1%
stock -3% · XLV +14%
matured Feb 24, 24
RBC Capital 
Feb 23, 23
▲ Outperform · 🎯$285
Price at call : $235.18 — upside +21%
Today : $137.71 — upside +107%
Expected +21% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 0% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-3.1%
stock -3% · XLV +14%
matured Feb 23, 24
Stephens & Co. 
Dec 28, 22
▲ Overweight · 🎯$295
Price at call : $247.55 — upside +19%
Today : $137.71 — upside +114%
Expected +19% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 45% (11 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
+0.9%
stock +1% · XLV +1%
matured Dec 28, 23
Stephens & Co. 
Oct 28, 22
▲ Overweight · 🎯$280
Price at call : $214.56 — upside +30%
Today : $137.71 — upside +103%
Expected +30% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 45% (11 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
-16.4%
stock -16% · XLV -7%
matured Oct 28, 23
Raymond James 
Oct 28, 22
▲ Outperform · 🎯$231
Price at call : $214.13 — upside +8%
Today : $137.71 — upside +68%
Expected +8% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 8% (12 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
-16.2%
stock -16% · XLV -7%
matured Oct 28, 23
Raymond James 
Aug 1, 22
▲ Outperform · 🎯$266
Price at call : $245.3 — upside +8%
Today : $137.71 — upside +93%
Expected +8% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 8% (12 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
+1.6%
stock +2% · XLV +2%
matured Aug 1, 23
Raymond James 
May 23, 22
▲ Outperform · 🎯$325
Price at call : $289.36 — upside +12%
Today : $137.71 — upside +136%
Expected +12% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 8% (12 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
-18.0%
stock -18% · XLV -1%
matured May 23, 23
Raymond James 
Apr 29, 22
▲ Outperform · 🎯$355
Price at call : $282.53 — upside +26%
Today : $137.71 — upside +158%
Expected +26% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 8% (12 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
-3.0%
stock -3% · XLV +4%
matured Apr 29, 23
Raymond James 
Feb 25, 22
▲ Outperform · 🎯$380
Price at call : $343.01 — upside +11%
Today : $137.71 — upside +176%
Expected +11% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 8% (12 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
-30.3%
stock -30% · XLV -2%
matured Feb 25, 23
Raymond James 
Feb 23, 22
▲ Outperform · 🎯$370
Price at call : $322.35 — upside +15%
Today : $137.71 — upside +169%
Expected +15% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 8% (12 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
-26.9%
stock -27% · XLV +3%
matured Feb 23, 23
Raymond James 
Oct 29, 21
▲ Outperform · 🎯$391
Price at call : $359.24 — upside +9%
Today : $137.71 — upside +184%
Expected +9% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 8% (12 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
-40.3%
stock -40% · XLV -1%
matured Oct 29, 22
Morgan Stanley 
Oct 29, 21
▲ Overweight · 🎯$431
Price at call : $359.24 — upside +20%
Today : $137.71 — upside +213%
Expected +20% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 58% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
-40.3%
stock -40% · XLV -1%
matured Oct 29, 22
Morgan Stanley 
Apr 30, 21
▲ Overweight · 🎯$478
Price at call : $422.48 — upside +13%
Today : $137.71 — upside +247%
Expected +13% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 58% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
-33.1%
stock -33% · XLV +7%
matured Apr 30, 22
Raymond James 
Mar 12, 21
▲ Strong Buy · 🎯$480
Price at call : $423.5 — upside +13%
Today : $137.71 — upside +249%
Expected +13% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 8% (12 calls matureds) · 📊 on Health : 39.9% · -2.0% (218 calls)
-21.0%
stock -21% · XLV +13%
matured Mar 12, 22
Morgan Stanley 
Dec 15, 20
▲ Overweight · 🎯$450
Price at call : $397.33 — upside +13%
Today : $137.71 — upside +227%
Expected +13% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 58% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
-20.0%
stock -20% · XLV +24%
matured Dec 15, 21
Morgan Stanley 
Oct 30, 20
▲ Overweight · 🎯$375
Price at call : $319.97 — upside +17%
Today : $137.71 — upside +172%
Expected +17% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 58% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+12.3%
stock +12% · XLV +29%
matured Oct 30, 21
Morgan Stanley 
Jul 31, 20
▲ Overweight · 🎯$400
Price at call : $373.65 — upside +7%
Today : $137.71 — upside +190%
Expected +7% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 58% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+4.7%
stock +5% · XLV +24%
matured Jul 31, 21
▲ Overweight · 🎯$380
Price at call : $329.37 — upside +15%
Today : $137.71 — upside +176%
Expected +15% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on TFX : 58% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+26.7%
stock +27% · XLV +25%
matured May 1, 21
Morgan Stanley 
Mar 27, 20
▲ Overweight · 🎯$350
Price at call : $288.34 — upside +21%
Today : $137.71 — upside +154%
Expected +21% · Actual +44% · Reason (≥ +15%) : ✓ Yes
🎯 on TFX : 58% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+44.2%
stock +44% · XLV +32%
matured Mar 27, 21
Stephens & Co. 
Mar 23, 20
▲ Overweight · 🎯$275
Price at call : $255.88 — upside +7%
Today : $137.71 — upside +100%
Expected +7% · Actual +58% · Reason (≥ +15%) : ✓ Yes
🎯 on TFX : 45% (11 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
+57.8%
stock +58% · XLV +42%
matured Mar 23, 21
Stephens & Co. 
Feb 21, 20
▲ Overweight · 🎯$425
Price at call : $370.4 — upside +15%
Today : $137.71 — upside +209%
Expected +15% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 45% (11 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
+4.4%
stock +4% · XLV +10%
matured Feb 20, 21
Morgan Stanley 
Dec 17, 19
▲ Overweight · 🎯$405
Price at call : $367.23 — upside +10%
Today : $137.71 — upside +194%
Expected +10% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 58% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+8.2%
stock +8% · XLV +10%
matured Dec 16, 20
▲ Overweight · 🎯$392
Price at call : $350.6 — upside +12%
Today : $137.71 — upside +185%
Expected +12% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on TFX : 58% (12 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+6.6%
stock +7% · XLV +20%
matured Aug 1, 20
Stephens & Co. 
May 22, 15
▲ Overweight · 🎯$147
Price at call : $129.72 — upside +13%
Today : $137.71 — upside +7%
Expected +13% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on TFX : 45% (11 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
+22.1%
stock +22% · XLV -7%
matured May 21, 16

Frequently asked questions

Should I buy Teleflex stock?

This isn't buy advice. For Teleflex, the analyst consensus is "Buy", with an average price target of $155 (+13% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (4 calls tracked on Teleflex). We show the numbers — you decide.

Is it too late to buy Teleflex? How high can it go?

The most bullish analyst target on Teleflex is $170 (+23% above today's price); the average is $155. That's the upside they see. Check how reliable those analysts have actually been on Teleflex on our site before trusting it.

Is Teleflex still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 16 analysts have a real record on Teleflex, the best hitting 100% over 4 calls. Current consensus: "Buy". Make your call on data, not noise.

Should you invest in Teleflex? The case for and against

The arguments for and against, one by one, from the numbers: why invest in TFX (and why hesitate).

What has Teleflex's past performance been?

Historical returns and a "how much if I had invested" calculator: TFX performance & returns.

What is the best month to buy TFX?

The 12 months ranked by the stock's past returns: best & worst month to buy TFX.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)